Viridian Therapeutics Inc Working Capital to Net Assets Ratio
Viridian Therapeutics Inc working capital to net assets ratio. Viridian Therapeutics Inc (VRDN) has a Working Capital to Net Assets ratio of 115.2% as of March 2026. Working capital of $732.94 Million (current assets of $784.74 Million minus current liabilities of $51.80 Million) is measured against net assets of $636.01 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check VRDN tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Viridian Therapeutics Inc (2012–2025)
Working capital to net assets ratio of Viridian Therapeutics Inc from 2012 to 2025. This chart shows how Viridian Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 115.2%, reflecting working capital of $732.94 Million against net assets of $636.01 Million USD. See Viridian Therapeutics Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Viridian Therapeutics Inc Working Capital to Net Assets Ratio by Year (2012–2025)
Viridian Therapeutics Inc working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Viridian Therapeutics Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see VRDN asset base.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 114.0% | $823.54 Million | $722.17 Million | $894.23 Million | $70.70 Million | ▲ +11.2 pp |
| 2024 | 102.8% | $690.59 Million | $671.64 Million | $738.46 Million | $47.87 Million | ▼ -1.2 pp |
| 2023 | 104.0% | $459.84 Million | $442.02 Million | $486.48 Million | $26.64 Million | ▲ +5.0 pp |
| 2022 | 99.0% | $391.20 Million | $395.06 Million | $424.55 Million | $33.35 Million | ▼ -0.3 pp |
| 2021 | 99.4% | $186.53 Million | $187.72 Million | $200.16 Million | $13.64 Million | ▲ +0.3 pp |
| 2020 | 99.1% | $118.94 Million | $120.04 Million | $129.61 Million | $10.67 Million | ▼ -25.1 pp |
| 2019 | 124.2% | $19.56 Million | $15.75 Million | $29.74 Million | $10.18 Million | ▲ +9.9 pp |
| 2018 | 114.2% | $58.64 Million | $51.34 Million | $65.37 Million | $6.73 Million | ▼ -10.4 pp |
| 2017 | 124.6% | $47.97 Million | $38.51 Million | $51.87 Million | $3.90 Million | ▲ +24.6 pp |
| 2016 | 100.0% | $-326.00K | $-326.00K | $4.26 Million | $4.58 Million | ▲ +11.0 pp |
| 2015 | 89.0% | $9.27 Million | $10.41 Million | $11.73 Million | $2.47 Million | ▲ +9.0 pp |
| 2014 | 80.1% | $4.80 Million | $5.99 Million | $6.79 Million | $1.99 Million | ▲ +47.1 pp |
| 2013 | 33.0% | $667.77K | $2.03 Million | $2.05 Million | $1.39 Million | ▼ -69.4 pp |
| 2012 | 102.3% | $-21.94 Million | $-21.44 Million | $1.66 Million | $23.60 Million | — |